Ischemic preconditioning prevents ischemia-induced beta-adrenergic receptor sequestration

Area of Science:

• Cardiology
• Cell Biology
• Pharmacology

Background:

• Myocardial ischemia can trigger endogenous protection via preconditioning.
• The impact of preconditioning on beta1 adrenergic receptor (AR) signaling is not fully understood.
• A novel whole-cell assay system allows for quantification of cell surface beta-ARs without cell disruption.

Purpose of the Study:

• To investigate the effects of chemical/metabolic ischemia on beta1 AR sequestration and adenylyl cyclase activity.
• To determine if preconditioning can prevent beta1 AR sequestration induced by ischemia or beta-adrenergic stimulation.

Main Methods:

• Utilized HEK293T cells overexpressing beta1 ARs in a whole-cell assay system.
• Administered isoproterenol or forskolin to assess receptor dynamics and adenylyl cyclase activity.
• Induced chemical/metabolic ischemia using potassium cyanide and 2-deoxy-D-glucose, with and without preconditioning.

Main Results:

• Isoproterenol and chemical/metabolic ischemia both induced rapid beta1 AR sequestration.
• Combined isoproterenol and ischemia resulted in greater sequestration.
• Chemical preconditioning significantly attenuated beta1 AR sequestration caused by both isoproterenol and ischemia.
• Adenylyl cyclase activity decreased with ischemia but recovered within 24 hours, indicating preserved cell viability.

Conclusions:

• Chemical/metabolic ischemia mimics isoproterenol in inducing beta1 AR sequestration.
• Preconditioning effectively prevents beta1 AR sequestration induced by both ischemic events and beta-adrenergic stimulation.
• Preconditioning may protect myocardial cells by maintaining cell surface beta1 ARs during ischemic or adrenergic stress.